PL2364712T3 - Miejscowa kompozycja kosmetyczna lub farmaceutyczna zawierająca probiotyczne szczepy pałeczek bakterii kwasu mlekowego i jej stosowanie - Google Patents

Miejscowa kompozycja kosmetyczna lub farmaceutyczna zawierająca probiotyczne szczepy pałeczek bakterii kwasu mlekowego i jej stosowanie

Info

Publication number
PL2364712T3
PL2364712T3 PL10156192T PL10156192T PL2364712T3 PL 2364712 T3 PL2364712 T3 PL 2364712T3 PL 10156192 T PL10156192 T PL 10156192T PL 10156192 T PL10156192 T PL 10156192T PL 2364712 T3 PL2364712 T3 PL 2364712T3
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
same
lactobacillus strains
topical cosmetic
probiotic lactobacillus
Prior art date
Application number
PL10156192T
Other languages
English (en)
Inventor
Alexandra Lopes
Anne Marie Lheritier
Christine Mielcarek
Patrice Malard
Original Assignee
Kloarys Invest Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kloarys Invest Ltd filed Critical Kloarys Invest Ltd
Publication of PL2364712T3 publication Critical patent/PL2364712T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/894—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL10156192T 2010-03-11 2010-03-11 Miejscowa kompozycja kosmetyczna lub farmaceutyczna zawierająca probiotyczne szczepy pałeczek bakterii kwasu mlekowego i jej stosowanie PL2364712T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10156192A EP2364712B1 (en) 2010-03-11 2010-03-11 Topical cosmetic or pharmaceutical composition comprising probiotic lactobacillus strains and use of same

Publications (1)

Publication Number Publication Date
PL2364712T3 true PL2364712T3 (pl) 2013-08-30

Family

ID=42335239

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10156192T PL2364712T3 (pl) 2010-03-11 2010-03-11 Miejscowa kompozycja kosmetyczna lub farmaceutyczna zawierająca probiotyczne szczepy pałeczek bakterii kwasu mlekowego i jej stosowanie

Country Status (4)

Country Link
EP (1) EP2364712B1 (pl)
DK (1) DK2364712T3 (pl)
ES (1) ES2408954T3 (pl)
PL (1) PL2364712T3 (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
AU2013299605A1 (en) 2012-08-07 2015-03-26 TopGeniX, Inc. Topical composition comprising transformed bacteria expressing a compound of interest
ITMI20130793A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
CN118979001A (zh) 2014-06-17 2024-11-19 皇冠实验室有限公司 经遗传修饰的细菌和用于细菌的遗传修饰的方法
JP2017519823A (ja) 2014-06-17 2017-07-20 トップジェニックス, インク.Topgenix, Inc. Ｕｖ保護用局所製剤
EP3196318A1 (en) 2016-01-19 2017-07-26 Symrise AG Probiotics for altering the composition of oral biofilms
EP3405205B1 (en) 2016-01-19 2020-07-15 Symrise AG Probiotics for use as anti-inflammatory agents in the oral cavity
WO2017147507A1 (en) 2016-02-24 2017-08-31 Xycrobe Therapeutics, Inc. Skin probiotic formulation
ITUA20162013A1 (it) 2016-03-24 2017-09-24 Probiotical Spa Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
JP2019510036A (ja) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティクス／プレバイオティクス有効成分を含む清浄剤組成物
EP3435765A1 (en) 2016-03-31 2019-02-06 Gojo Industries, Inc. Antimicrobial peptide stimulating sanitizing composition
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
US11564879B2 (en) 2016-11-23 2023-01-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
EP3351259A1 (en) 2017-01-18 2018-07-25 Symrise AG Probiotics for aggregation with disease-associated species in the oral cavity
CN108004187B (zh) * 2018-01-11 2020-03-10 广东龙创基药业有限公司 一种格氏乳杆菌及其用于制备阴道抑菌药物的应用
WO2020001747A1 (en) * 2018-06-26 2020-01-02 Symrise Ag Lactobacillus plantarum for skin care
WO2020007931A1 (en) * 2018-07-04 2020-01-09 Chr. Hansen A/S Topical compositions comprising viable probiotic bacteria
JP2022517754A (ja) 2019-01-04 2022-03-10 ラクトバイオ アー／エス 菌株、組成物および使用方法
JP2021042172A (ja) * 2019-09-12 2021-03-18 株式会社アノワ 女性ｄｚ塗布用組成物
CN110721150B (zh) * 2019-11-29 2022-09-30 广州环亚化妆品科技股份有限公司 一种婴儿护臀霜及其制备方法
BR112022026237A2 (pt) 2020-06-23 2023-01-17 Crown Laboratories Inc Formulações probióticas para a pele
WO2022003062A1 (en) 2020-06-30 2022-01-06 Biogaia Ab Probiotic composition for topical use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1758937A (en) * 1925-12-05 1930-05-20 George H Earp-Thomas Lactobacteria product
EP1110555A1 (fr) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Agent anti-adhesion de la flore pathogene de la peau
US20040022775A1 (en) * 2002-04-15 2004-02-05 Gregor Reid Methods of treating viral infections in mammals
SE525647C2 (sv) * 2003-01-03 2005-03-29 Sca Hygiene Prod Ab Hygientissue för rengöring av och överföring av mjölksyraproducerande bakterier till huden och det urogenitila området
US20080107699A1 (en) * 2006-10-25 2008-05-08 Mark Spigelman Method of using topical probiotics for the inhibition of surface contamination by a pathogenic microorganism and composition therefor

Also Published As

Publication number Publication date
EP2364712B1 (en) 2013-03-06
EP2364712A1 (en) 2011-09-14
DK2364712T3 (da) 2013-05-21
ES2408954T3 (es) 2013-06-24

Similar Documents

Publication Publication Date Title
DK2364712T3 (da) Topisk, kosmetisk eller farmaceutisk sammensætning, der omfatter probiotiske Lactobacillus-stammer, og anvendelse heraf
EP2563372A4 (en) PREBIOTIC FORMULATIONS AND METHODS OF USE
ZA201205683B (en) Probiotic composition for use in the treatment of bowel inflammation
ZA201303600B (en) Composition i-ii and products and uses thereof
EP2544656A4 (en) PROBIOTIC COLORED COSMETIC COMPOSITIONS AND METHODS
SG11201402962WA (en) Strain of exopolysaccharide-secreting lactobacillus plantarum and application thereof
EP2613802A4 (en) ENVIRONMENTAL CLOSTRIDAL BACTERIOTHERAPY AND ASSOCIATED FORMULATIONS AND METHODS OF MAKING AND USING SAME
EP2621504A4 (en) COMPOSITION FOR PERSONAL HYGIENE CARE CONTAINING YEAST EXTRACT AND HEXAPEPTIDE
PL2544698T3 (pl) Kompozycja zawierająca bakterie probiotyczne do zastosowania w leczeniu zaburzeń odporności
SG11201402961VA (en) Strain of exopolysaccharide-secreting lactobacillus brevis and application thereof
IL221043A0 (en) Modified release formulation and methods of use
PL2655595T3 (pl) Nowa bakteria i ekstrakty ze wspomnianej bakterii oraz ich zastosowanie w dermatologii
GB2479035B (en) Cosmetic or dermatological composition comprising the combination of honey and a peptide
SG10201502583VA (en) Immunogenic proteins and compositions for the treatment and prevention of streptococcus agalactiae
PT2407151T (pt) Composição para o tratamento de lesões da pele e/ou unhas
IL212698A0 (en) Pharmaceutical preparation comprising a combination of streptococcus strains and lactobacillus strains
PL2457576T3 (pl) Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji
PL2521445T3 (pl) Preparat i jego zastosowanie
GB201222455D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
IL220738A0 (en) Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereof
SG10201405125YA (en) Composition for hair cosmetic preparation and production method of the same
GB201507037D0 (en) Modified BCG strains with reduced or eliminated activity of LSR2 and pharmaceutical composition comprising same
LT2525827T (lt) Loratadino farmacinės kompozicijos, skirtos kapsuliavimui ir jų kombinacijos
IL224191A (en) Compositions of vitamin d and cmc epi-14 analogues
ZA201304460B (en) Novel bacterium and extracts of said bacterium and the use of same in therapy